{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T09:43:29Z","timestamp":1777196609000,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jsbmb.2015.08.016","type":"journal-article","created":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T12:37:26Z","timestamp":1439815046000},"page":"186-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration"],"prefix":"10.1016","volume":"154","author":[{"given":"Yuyong","family":"Ke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernand","family":"Labrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renaud","family":"Gonthier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Nicolas","family":"Simard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Martel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Vaillancourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlene","family":"Montesino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyne","family":"Lavoie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Balser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erick","family":"Moyneur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jsbmb.2015.08.016_bib0001","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4065\/mcp.2009.0413","article-title":"Vulvovaginal atrophy","volume":"85","author":"Mac Bride","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0002","series-title":"The Merck Manual of Diagnosis, Therapy","article-title":"Gynecology and obstetrics","author":"Beers","year":"2015"},{"issue":"2","key":"10.1016\/j.jsbmb.2015.08.016_bib0003","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.maturitas.2009.03.021","article-title":"Menopause and sexuality: prevalence of symptoms and impact on quality of life","volume":"63","author":"Nappi","year":"2009","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.jsbmb.2015.08.016_bib0004","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-5122(91)90284-W","article-title":"Sexuality in sexagenarian women","volume":"13","author":"Bachmann","year":"1991","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.jsbmb.2015.08.016_bib0005","first-page":"228","article-title":"Postmenopausal vaginal atrophy and atrophic vaginitis","volume":"314","author":"Pandit","year":"1997","journal-title":"Am. J. Med. Sci."},{"issue":"4","key":"10.1016\/j.jsbmb.2015.08.016_bib0006","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3109\/00016349309068039","article-title":"Factors influencing vaginal cytology, pH and bacterial flora in elderly women","volume":"72","author":"Milsom","year":"1993","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"4","key":"10.1016\/j.jsbmb.2015.08.016_bib0007","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.maturitas.2009.04.009","article-title":"Managing urogenital atrophy","volume":"63","author":"Palacios","year":"2009","journal-title":"Maturitas"},{"issue":"5","key":"10.1016\/j.jsbmb.2015.08.016_bib0008","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1529-8019.2010.01354.x","article-title":"Atrophic vaginitis","volume":"23","author":"Stika","year":"2010","journal-title":"Dermatol. Ther."},{"issue":"1","key":"10.1016\/j.jsbmb.2015.08.016_bib0009","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/gme.0b013e31821f92df","article-title":"Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review","volume":"19","author":"Tan","year":"2012","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.jsbmb.2015.08.016_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/13697137.2013.871696","article-title":"Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause","volume":"17","author":"Nappi","year":"2014","journal-title":"Climacteric"},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0011","first-page":"105","article-title":"Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy","volume":"1","author":"Kingsberg","year":"2010","journal-title":"Int. J. Womens Health"},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0012","unstructured":"Guidance for Industry, Bioanalytical Method Validation. May, (2001)."},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0013","unstructured":"Guidance for Industry, Bioanalytical Method Validation\u2014Revision 1. U.S. Department of Health and Human Services, Food and Drug Administration. Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM). Division of Drug Information, W051, Room 2201, Center for Drug Evaluation and Research, Food and Drug Administration, September (Draft Guidance). http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm, (2013)."},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0014","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jsbmb.2014.08.015","article-title":"A sensitive, simple and robust LC\u2013MS\/MS method for the simultaneous quantification of seven androgen- and estrogen-related steroids in postmenopausal serum","volume":"144","author":"Ke","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jsbmb.2015.02.009","article-title":"A rapid and sensitive UPLC-MS\/MS method for the simultaneous quantification of serum androsterone glucuronide, etiocholanolone glucuronide, and androstan-3alpha, 17beta diol 17-glucuronide in postmenopausal women","volume":"149","author":"Ke","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2015.01.006","article-title":"Validated LC\u2013MS\/MS simultaneous assay of five sex steroid\/neurosteroid-related sulfates in human serum","volume":"149","author":"Dury","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0017","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jsbmb.2015.02.003","article-title":"Why both LC\u2013MS\/MS and FDA-compliant validation are essential for accurate estrogen assays?","volume":"149","author":"Labrie","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3\u20135","key":"10.1016\/j.jsbmb.2015.08.016_bib0018","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jsbmb.2008.06.003","article-title":"Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women","volume":"111","author":"Labrie","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0019","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jsbmb.2013.08.002","article-title":"Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens","volume":"138","author":"Labrie","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.jsbmb.2015.08.016_bib0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/13697137.2010.483297","article-title":"Minimized estradiol absorption with ultra-low-dose 10 microg 17beta-estradiol vaginal tablets","volume":"13","author":"Eugster-Hausmann","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0021","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsbmb.2008.11.004","article-title":"Comparable amounts of sex steroids are made outside the gonads in men and women: strong lesson for hormone therapy of prostate and breast cancer","volume":"113","author":"Labrie","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"11","key":"10.1016\/j.jsbmb.2015.08.016_bib0022","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1097\/gme.0b013e3182227ebd","article-title":"Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women\u2019s Health Initiative","volume":"18","author":"Gass","year":"2011","journal-title":"Menopause"},{"issue":"7","key":"10.1016\/j.jsbmb.2015.08.016_bib0023","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/jsm.12190","article-title":"Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women\u2019s VIews of Treatment Options for Menopausal Vaginal ChangEs) survey","volume":"10","author":"Kingsberg","year":"2013","journal-title":"J. Sex Med."},{"issue":"5","key":"10.1016\/j.jsbmb.2015.08.016_bib0024","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/ijc.27711","article-title":"Global estimates of cancer prevalence for 27 sites in the adult population in 2008","volume":"132","author":"Bray","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0025","doi-asserted-by":"crossref","first-page":"C113","DOI":"10.1016\/0303-7207(91)90116-A","article-title":"Intracrinology","volume":"78","author":"Labrie","year":"1991","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0026","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1210\/endo-123-3-1412","article-title":"Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate","volume":"123","author":"Labrie","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0027","series-title":"Important Advances in Oncology","first-page":"193","article-title":"Complete androgen blockade for the treatment of prostate cancer","author":"Labrie","year":"1985"},{"issue":"2","key":"10.1016\/j.jsbmb.2015.08.016_bib0028","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.beem.2008.01.001","article-title":"Inactivation of androgens by UDP-glucuronosyltransferases in the human prostate","volume":"22","author":"Barbier","year":"2008","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0029","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0022-4731(89)90514-1","article-title":"Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: unique importance of extratesticular androgens in men","volume":"32","author":"B\u00e9langer","year":"1989","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0030","first-page":"14","article-title":"DHEA after menopause\u2014sole source of sex steroids and potential sex steroid deficiency treatment","volume":"19","author":"Labrie","year":"2010","journal-title":"Menopause Manage."},{"issue":"1","key":"10.1016\/j.jsbmb.2015.08.016_bib0031","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/gme.0b013e3181e195a6","article-title":"Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary?","volume":"18","author":"Labrie","year":"2011","journal-title":"Menopause"},{"issue":"10","key":"10.1016\/j.jsbmb.2015.08.016_bib0032","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.tem.2003.10.005","article-title":"Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans","volume":"14","author":"Belanger","year":"2003","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0033","first-page":"131","article-title":"Intracrinology in action: importance of extragonadal sex steroid biosynthesis and inactivation in peripheral tissues in both women and men","volume":"145","author":"Labrie","year":"2015","journal-title":"JSBMB"},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0034","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jsbmb.2006.02.004","article-title":"Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women","volume":"99","author":"Labrie","year":"2006","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0035","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/gme.0b013e31819e8e2d","article-title":"Intravaginal dehydroepiandrosterone (Prasterone) a physiological and highly efficient treatment of vaginal atrophy","volume":"16","author":"Labrie","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0036","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/13697137.2010.535226","article-title":"Intravaginal dehydroepiandrosterone (DHEA, Prasterone), a highly efficient treatment of dyspareunia","volume":"14","author":"Labrie","year":"2011","journal-title":"Climacteric"},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0037","article-title":"Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepaindrosterone (prasterone)","volume":"22","author":"Archer","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0038","article-title":"Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy and of the genitourinary syndrome of menopause","volume":"23","author":"Labrie","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0039","doi-asserted-by":"crossref","DOI":"10.3109\/13697137.2015.1077508","article-title":"Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner","author":"Labrie","year":"2015","journal-title":"Climacteric"},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/13697137.2012.733983","article-title":"DHEA and intracrinology at menopause, a positive choice for evolution of the human species","volume":"16","author":"Labrie","year":"2013","journal-title":"Climacteric"},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0041","first-page":"133","article-title":"All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause","volume":"145","author":"Labrie","year":"2015","journal-title":"JSBMB"},{"issue":"4","key":"10.1016\/j.jsbmb.2015.08.016_bib0042","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/0969733010364584","article-title":"Ethical practice in end-of-life care in Japan","volume":"17","author":"Izumi","year":"2010","journal-title":"Nurs. Ethics"},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0043","unstructured":"Census Browser University of Virginia, Geospatial and Statistical Data Center. Available at http:\/\/fisher.lib.virginia.edu\/collections\/stats\/hist-census\/index.html (2010) April 25"},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0044","unstructured":"IMS Health Plan Claim (April 2008\u2013March 2011)."},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0045","first-page":"161","article-title":"Assessment of steroidogenic pathways that do not require testosterone as intermediate","volume":"5","author":"Luu-The","year":"2011","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"key":"10.1016\/j.jsbmb.2015.08.016_bib0046","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1677\/joe.1.06264","article-title":"Is DHEA a hormone? Starling review","volume":"187","author":"Labrie","year":"2005","journal-title":"J. Endocrinol."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076015300492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076015300492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:49:28Z","timestamp":1760744968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076015300492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":46,"alternative-id":["S0960076015300492"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2015.08.016","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2015.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}